Viewing Study NCT04639050

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 4:55 PM

Ignite Modification Date: 2026-01-07 @ 4:43 AM

Study NCT ID: NCT04639050

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2025-12-23

First Post: 2020-11-17

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease

Sponsor: Hoffmann-La Roche

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module